Are Tryptophan and Serotonin Alteration Act as a Trigger Biomarker for Type 2 Diabetes Complications?
Abstract Tryptophan (Trp) is a vital amino acid causing clinical implications in the human body and biological specimens. Serotonin (5-HT) is well-recognized for its biological activities in the brain, and as a familiar neurotransmitter, it regulates various neuropsychological processes. Alterations in the serotonergic system were proved to play a role in the pathogenesis of different neurological and psychiatric diseases. In recent years, Trp and 5-HT levels have been considered as triggers of diabetes mellitus (DM). The altered Trp metabolism may also play roles in the pathogenesis of DM and developing a risk of complications. The whole blood (WB) 5-HT level was mainly lower among diabetic patients compared to others. That is mostly derived from a lower platelet concentration of 5-HT in these patients. Indeed, 5-HT level can be considered as a potent biomarker for early detection of DM complications. Besides, it was proved that outside the digestive and central nervous systems, 5-HT was discovered in beta cells, and scientists have been attempting to realize its mechanism of action ever since. Towards to end, the determination methods, biomarker’s role, and approaches of 5-HT and Trp levels were thoroughly investigated in both healthy and diabetic patients with or without complications. Moreover, the association between insulin and 5-HT has been specifically discussed. Our study concluded that Trp and 5-HT levels could be exclusively applied for early diagnosis of DM complications as well as many other complications.